Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 108.79
  • 0.88  0.82%
    Today's Change
  • 107.91
    Previous Close
  • Today
    52 Week Low - High
5:20 pm ET 8/26/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding775 million
Market Cap$84 billion
Return on Equity ttm32.45%
Last DividendCELG:US does not pay a dividend
EPS: Year Actual ttm2.895
EPS: Year Est. 12/16 ttm5.769
EPS: Quarterly Actual 6/16 1.44
EPS: Quarterly Est. 9/16 1.48
Price/Earnings ttm37.58
Relative Price/Earnings1.845
Earnings Growth Rate-18.88
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$9 billion
Net Income$2 billion
Total Assets$27 billion
Web Sitewww.celgene.com

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!